ANDA 203024, held by L Perrigo Co. Pantoprazole Sodium.
As of Nov 15, 2026, ANDA 203024 (Pantoprazole Sodium), held by L Perrigo Co, was first approved by FDA on May 7, 2014, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 7, 2014 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Pantoprazole SodiumEQ 20MG BASE ยท tablet, delayed release;oral | Pantoprazole Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
